Charles River Laboratories (CRL)

NYSE
Currency in USD
Disclaimer
259.26
+6.62
(+2.62%)
Real-time Data
Earnings results expected in 7 days
Day's Range
252.65
262.00
52 wk Range
181.36
349.84
Volume
540,741
Prev. Close
252.64
Open
253.51
Day's Range
252.65-262
52 wk Range
181.36-349.84
Volume
540,741
Average Volume (3m)
577,960
1-Year Change
-24.53%
Shares Outstanding
50,878,656
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
266.17
Upside +2.34%

People Also Watch

493.10
HUM
+2.51%
73.64
CNC
+3.75%
158.07
ABC
+0.82%
438.51
CTAS
-1.03%

Charles River Laboratories News

Charles River Laboratories Analysis

Charles River Laboratories Company Profile

Charles River Laboratories International, Inc. is a full service, non-clinical contract research company. The Company provides research models required in research and development of new drugs, devices, and therapies. The Company's segments include Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and GMP-compliant cells businesses. The DSA segment includes services required to take a drug through the early development process, including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions (Biologics), and Avian Vaccine Services (Avian).